RecruitingPhase 3NCT05906758

Ultra-Low Contrast Angiography in AKI

Randomized Controlled Trial of Ultra-Low Contrast Coronary Angiography During Acute Kidney Injury (AKI)

Sponsor

Tulane University

Enrollment

32 participants

Start Date

Sep 5, 2025

Study Type

INTERVENTIONAL

Conditions

The aim of this study is to evaluate the safety of ultra-low contrast coronary angiography in patients with pre-existing acute kidney injury.

Min Age: 18 YearsMax Age: 100 Years

Hospitalized patients who have AKI at admission or who develop AKI during admission and require invasive coronary angiography will be included in the trial.

Stabilized renal function manifested by unchanged or downtrending serum creatinine during a 24-hour period prior to enrollment.
Contraindication for invasive coronary angiography other than AKI.
Percutaneous coronary intervention is indicated and cannot be postponed by 7 days.
Need for renal replacement therapy before coronary angiography or planned renal replacement therapy after coronary angiography (if premeditated before coronary angiography).
Administration of intravascular contrast media during 7 days prior to the coronary angiography or within 6 days after coronary angiography.
Pregnant patients, prisoners, cognitively impaired subjects, age below 18 years, unable or unwilling to provide informed consent.

Interested in this trial?

Get notified about updates and connect with the research team.